Related Experiment Video
Updated: Feb 21, 2026

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients
Masaru Obokata1, Kazuaki Negishi2,3, Hiroaki Sunaga1
1Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Insights
Elevated serum β-hydroxybutyrate (βOHB) levels in hemodialysis patients correlate with a higher risk of cardiovascular events and death. This finding suggests βOHB may be a significant biomarker for adverse outcomes in this population.
Area of Science:
- Nephrology
- Cardiology
- Metabolic Science
Background:
- Cardiovascular disease (CVD) is a primary cause of death in hemodialysis patients.
- Metabolic disturbances are common in patients with high cardiovascular risk.
- The role of ketone bodies in hemodialysis patient outcomes requires further investigation.
Purpose of the Study:
- To investigate the association between serum β-hydroxybutyrate (βOHB) levels and clinical outcomes in hemodialysis patients.
- To determine if βOHB can serve as a predictive biomarker for cardiovascular events and mortality.
Main Methods:
- Retrospective analysis of 405 stable hemodialysis patients.
- Measurement of serum βOHB levels.
- Follow-up for major adverse cardiovascular events (MACE) and all-cause mortality.
Main Results:
- Higher serum βOHB levels were linked to increased rates of MACE and all-cause death.
- The highest βOHB quintile showed a significantly elevated risk of MACE (HR, 10.2; P<0.001) after adjustment.
- βOHB levels independently and incrementally predicted MACE, outperforming established risk scores.
Conclusions:
- Increased serum βOHB is an independent predictor of cardiovascular events and mortality in hemodialysis patients.
- These findings underscore the potential clinical utility of βOHB as a prognostic marker.
- Further research is needed to elucidate the underlying mechanisms connecting βOHB to adverse outcomes.
Background:
Cardiovascular disease is the leading cause of morbidity and mortality in patients receiving hemodialysis. Systemic metabolic perturbation is one of the hallmark abnormalities in patients at high cardiovascular risk. We sought to determine the relationship between circulating ketone body and clinical outcomes in patients with prevalent hemodialysis.
Methods And Results:
We retrospectively assessed the relationship between serum β-hydroxybutyrate (βOHB), the most abundant ketone body in the circulation, and prognosis in 405 stable hemodialysis patients. During a mean follow-up of 3.2±0.9 years, there were 54 major adverse cardiovascular events (defined as cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and hospitalization attributed to heart failure) and 67 all-cause deaths. Major adverse cardiovascular events rates increased from 11.1 per 1000 person-years in the lowest βOHB quintile (<89 μmol/L) to 80.1 per 1000 person-years in the highest quintile (>409 μmol/L). After adjusting for demographic characteristics, coronary artery disease, and atrial fibrillation, the highest βOHB quintile was associated with increased risk of major adverse cardiovascular events compared with the lowest quintile (hazard ratio, 10.2; 95% confidence interval [3.35-44.0]; P<0.001). Increased quintiles of βOHB were independently and incrementally associated with major adverse cardiovascular events over the model based on an established risk score (the second Analyzing Data, Recognizing Excellence and Optimizing Outcomes cohort score) and N-terminal pro-B-type natriuretic peptide (chi square 39.9 versus 21.7; P<0.001; c-statistics, 0.713). Sensitivity analyses also confirmed the robustness of association between βOHB and all-cause death.
Conclusions:
Increased serum βOHB levels were independently associated with cardiovascular events and all-cause death in patients receiving hemodialysis. These results highlight the need for future studies to understand the mechanisms underlying these observations.
More Related Videos
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Hemodialysis II: Procedure and Complications
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Chronic Kidney Disease III: Interprofessional Care
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Kidney Disease I: Introduction

